Effect of different growth factors on human osteoblasts activities: A possible application in bone regeneration for tissue engineering

Biomolecular Engineering - Tập 24 Số 6 - Trang 613-618 - 2007
Michela Bosetti1, Francesca Boccafoschi, Massimiliano Leigheb, Mario Cannas
1Department of Clinical and Experimental Medicine, School of Medicine, University of Eastern Piedmont, Via Solaroli 17, 28100 Novara, Italy.

Tóm tắt

Từ khóa


Tài liệu tham khảo

Blonder, 2006, Proteomic profiling of differentiating osteoblasts, Expert Rev. Proteomics, 3, 483, 10.1586/14789450.3.5.483

Bosetti, 2001, In vitro characterisation of zirconia coated by bioactive glass, Biomaterials, 22, 987, 10.1016/S0142-9612(00)00264-7

Erlebacher, 1995, Toward a molecular understanding of skeletal development, Cell, 80, 371, 10.1016/0092-8674(95)90487-5

Franceschi, 2005, Biological approaches to bone regeneration by gene therapy, J. Dent. Res., 84, 1093, 10.1177/154405910508401204

Frechette, 2005, Platelet-rich plasmas: growth factor content and roles in wound healing, J. Dent. Res., 84, 434, 10.1177/154405910508400507

Gonnerman, 2006, Effects of growth factors on cell migration and alkaline phosphatase release, Biomed. Sci. Instrum., 42, 60

Gurlek, 2001, Regulation of osteoblast growth by interactions between transforming growth factor-β and 1α,25-dihydroxyvitamin D3, Crit. Rev. Eukaryot. Gene Expr., 11, 299

Gurlek, 2002, Modulation of growth factor/cytokine synthesis and signaling by 1a,25-dihydroxyvitamin D3: implications in cell growth and differentiation, Endocr. Rev., 23, 763, 10.1210/er.2001-0044

Harada, 2003, Control of osteoblast function and regulation of bone mass, Nature, 423, 349, 10.1038/nature01660

Ho, 1999, Effects of nonsteroidal anti-inflammatory drugs and prostaglandins on osteoblastic functions, Biochem. Pharmacol., 58, 983, 10.1016/S0006-2952(99)00186-0

Jackson, 2007, Heparan sulfate regulates the anabolic activity of MC3T3-E1 preosteoblast cells by induction of runx2, J. Cell. Physiol., 210, 38, 10.1002/jcp.20813

Janssens, 2005, Transforming growth factor-β1 to the bone, Endocr. Rev., 26, 743, 10.1210/er.2004-0001

Jorgensen, 2004, Dexamethasone, BMP-2, and 1 25-dihydroxyvitamin D enhance a more differentiated osteoblast phenotype: validation of an in vitro model for human bone marrow-derived primary osteoblasts, Steroids, 69, 219, 10.1016/j.steroids.2003.12.005

Karsenty, 2006, Convergence between bone and energy homeostases: leptin regulation of bone mass, Cell Metab., 4, 341, 10.1016/j.cmet.2006.10.008

Kim, 2003, The protein kinase C pathway plays a central role in the fibroblast growth factor-stimulated expression and transactivation activity of Runx2, J. Biol. Chem., 278, 319, 10.1074/jbc.M203750200

Lee, 2006, Enhanced bone formation by transforming growth factor-beta1-releasing collagen/chitosan microgranules, J. Biomed. Mater. Res. A, 76, 530, 10.1002/jbm.a.30434

Lilli, 2002, Biomembranes enriched with TGFbeta1 favor bone matrix protein expression by human osteoblasts in vitro, J. Biomed. Mater. Res., 63, 577, 10.1002/jbm.10301

Mistry, 2005, Tissue engineering strategies for bone regeneration, Adv. Biochem. Eng. Biotechnol., 94, 1

Parades, 2004, Bone-specific transcription factor Runx2 interacts with the 1alpha,25-dihydroxyvitamin D3 receptor to up-regulate rat osteocalcin gene expression in osteoblastic cells, Mol. Cell. Biol., 24, 8847, 10.1128/MCB.24.20.8847-8861.2004

Qin, 2004, Parathyroid hormone: a double-edged sword for bone metabolism, Trends Endocrinol. Metab., 15, 60, 10.1016/j.tem.2004.01.006

Skjodt, 1992, Bone cell biology and the regulation of bone turnover, 1

Sobue, 2005, Over-expression of fibroblast growth factor-2 causes defective bone mineralization and osteopenia in transgenic mice, J. Cell. Biochem., 95, 83, 10.1002/jcb.20389

Sowa, 2002, Activations of ERK1/2 and JNK by transforming growth factor b negatively regulate Smad3-induced alkaline phosphatase activity and mineralization in mouse osteoblastic cells, J. Biol. Chem., 277, 36024, 10.1074/jbc.M206030200

Spector, 2005, FGF-2 acts through an ERK1/2 intracellular pathway to affect osteoblast differentiation, Plast. Reconstr. Surg., 115, 838, 10.1097/01.PRS.0000153035.73507.7B

Suda, 2003, Vitamin D and bone, J. Cell. Biochem., 88, 259, 10.1002/jcb.10331

Valta, 2006, Regulation of osteoblast differentiation: a novel function for fibroblast growth factor 8, Endocrinology, 147, 2171, 10.1210/en.2005-1502

Vanderschueren, 2004, Androgens and bone, Endocr. Rev., 25, 389, 10.1210/er.2003-0003

Van Leeuwen, 2001, Vitamin D control of osteoblast function and bone extracellular matrix mineralization, Crit. Rev. Eukaryot. Gene Expr., 11, 199

Zuo, 2004, Effects of basic fibroblast growth factor on osteoclasts and osteoclast-like cells, Biochem. Biophys. Res. Commun., 318, 162, 10.1016/j.bbrc.2004.04.013